Trends and prediction of antimicrobial susceptibility in urinary bacteria isolated in European emergency departments: the EuroUTI 2010-2016 Study


Por: Quaegebeur, A, Brunard, L, Javaudin, F, Vibet, M, Bemer, P, Le Bastard, Q, Batard, E, Montassier, E, Roman, F, Llorens, P, Salvi, F, Galeazzi, R, Ortega, M, Marco, F, de Zarate MMO, Ceron, R, Trovato, F, Carpinteri, G, Moustafa, F, Romaszko, J, Pedersen, M, Westh, H, Dejaune, P, Fihman, V, Joost, I, Blumel, B, Ruiz, F, Corral, G, Bieler, D, Bergmann, H, Granzer, H, Carron, P, Prod'hom, G, Greub, G, Del Castillo, J, Gonzalez, F, Juvin, M, Occelli, C, Ruimy, R, Claret, P, Lavigne, J, Hausfater, P, Robert, J, Ramacciati, N, Mencacci, A, Tartaglia, D, Rossi, L, Ojetti, V, Petruzziello, C, Fiori, B, Bonenfant, J, Piau-Couape, C, Dejoies, L, Garcia-Garcia, A, Cores-Calvo, O, Van den Brand, C, Van Veen, S, Laribi, S, Lartigue, M and EuroUTI 2010-2016 Study Grp

Publicada: 1 oct 2019
Resumen:
Objectives To assess recent trends in susceptibility to antibiotics among urinary isolates isolated in European emergency departments (EDs) and to identify isolates with a high (90% or more) predicted probability of susceptibility to fluoroquinolones or third-generation cephalosporins (3GCs). Methods In this cross-sectional study, we included urine cultures obtained from adult patients between 2010 and 2016 in 24 European EDs. Temporal trends were assessed using time-series analysis and multivariate logistic models. Multivariate logistic models were also used to predict susceptibility to fluoroquinolones or 3GCs from patient age and sex, year, month and ED. Results We included 88242 isolates. Time-series analysis found a significant increase in susceptibility to fluoroquinolones and no significant trend for susceptibility to 3GCs. Adjusting for patient age and sex, ED and organism, multivariate models showed that susceptibility to 3GCs decreased from 2014 to 2016, while susceptibility to fluoroquinolones increased in 2015 and 2016. Among isolates from 2016, multivariate models predicted high probability of susceptibility to fluoroquinolones in 11% of isolates (positive predictive value 91%) and a high probability of susceptibility to 3GCs in 35% of isolates (positive predictive value 94%). Conclusions Susceptibility of ED urinary isolates to fluoroquinolones increased from 2014, while susceptibility to 3GCs decreased from 2015. Predictive models identified isolates with a high probability of susceptibility to fluoroquinolones or 3GCs. The ability of such models to guide the empirical treatment of pyelonephritis in the ED remains to be determined.

Filiaciones:
Quaegebeur, A:
 Lausanne Univ Hosp, Emergency Dept, Lausanne, Switzerland

Brunard, L:
 CHU Nantes, Emergency Dept, Nantes, France

Javaudin, F:
 CHU Nantes, Emergency Dept, Nantes, France

 Univ Nantes, Microbiotas Hosts Antibiot Bacterial Resistances, Nantes, France

Vibet, M:
 Univ Nantes, Microbiotas Hosts Antibiot Bacterial Resistances, Nantes, France

 CHU Nantes, DRCI Plateforme Methodol & Biostat, Nantes, France

Bemer, P:
 Univ Nantes, Microbiotas Hosts Antibiot Bacterial Resistances, Nantes, France

 CHU Nantes, Bacteriol & Infect Control, Nantes, France

Le Bastard, Q:
 CHU Nantes, Emergency Dept, Nantes, France

 Univ Nantes, Microbiotas Hosts Antibiot Bacterial Resistances, Nantes, France

Batard, E:
 CHU Nantes, Emergency Dept, Nantes, France

 Univ Nantes, Microbiotas Hosts Antibiot Bacterial Resistances, Nantes, France

Montassier, E:
 CHU Nantes, Emergency Dept, Nantes, France

 Univ Nantes, Microbiotas Hosts Antibiot Bacterial Resistances, Nantes, France

:
 Hosp Gen Alicante, Emergency Dept, Alicante, Spain

:
 Hosp Gen Alicante, Emergency Dept, Alicante, Spain

Salvi, F:
 IRCCS, INRCA, Dept Geriatr & Emergency Care, Ancona, Italy

Galeazzi, R:
 IRCCS, INRCA, Chem & Mol Lab, Ancona, Italy

Ortega, M:
 Univ Barcelona, Hosp Clin Barcelona, Emergency Dept, Barcelona, Spain

Marco, F:
 Univ Barcelona, Hosp Clin Barcelona, Microbiol Dept, Barcelona, Spain

de Zarate MMO:
 Hosp Univ Basurto, Emergency Dept, Bilbao, Spain

Ceron, R:
 Hosp Univ Basurto, Microbiol Dept, Bilbao, Spain

Trovato, F:
 Univ Hosp Vittorio Emanuele, Emergency Dept, Catania, Italy

Carpinteri, G:
 Univ Hosp Vittorio Emanuele, Emergency Dept, Catania, Italy

Moustafa, F:
 CHU Clermont Ferrand, Clermont Ferrand, France

Romaszko, J:
 CHU Clermont Ferrand, Clermont Ferrand, France

Pedersen, M:
 Copenhagen Univ Hosp, Dept Clin Microbiol, Hvidovre, Denmark

Westh, H:
 Copenhagen Univ Hosp, Dept Clin Microbiol, Hvidovre, Denmark

Dejaune, P:
 CHU Henri Mondor, Creteil, France

Fihman, V:
 CHU Henri Mondor, Creteil, France

Joost, I:
 Univ Med Ctr Freiburg, Div Emergency Med, Freiburg, Germany

Blumel, B:
 Univ Med Ctr Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany

Ruiz, F:
 Alta Resoluc Hosp Guadix, Emergency Dept, Granada, Spain

Corral, G:
 Alta Resoluc Hosp Guadix, Microbiol Dept, Granada, Spain

Bieler, D:
 German Armed Forces Cent Hosp, Dept Trauma Surg & Orthoped, Koblenz, Germany

Bergmann, H:
 German Armed Forces Cent Hosp, Dept Anesthesiol Intens Care Med Emergency Med &, Koblenz, Germany

Granzer, H:
 German Armed Forces Cent Hosp, Microbiol Dept, Koblenz, Germany

Carron, P:
 Univ Hosp Lausanne, Emergency Dept, Lausanne, Switzerland

Prod'hom, G:
 Univ Hosp Lausanne, Inst Microbiol, Lausanne, Switzerland

Greub, G:
 Univ Hosp Lausanne, Inst Microbiol, Lausanne, Switzerland

Del Castillo, J:
 Hosp Clin Univ San Carlos, Emergency Dept, Madrid, Spain

Gonzalez, F:
 Hosp Clin Univ San Carlos, Dept Clin Microbiol, Madrid, Spain

Juvin, M:
 CHU Nantes, Bacteriol Dept, Nantes, France

Occelli, C:
 CHU Nice, Nice, France

Ruimy, R:
 CHU Nice, Nice, France

Claret, P:
 CHU Nimes, Nimes, France

Lavigne, J:
 CHU Nimes, Nimes, France

Hausfater, P:
 CHU Pitie Salpetriere, Paris, France

Robert, J:
 CHU Pitie Salpetriere, Paris, France

Ramacciati, N:
 Santa Maria Misericordia Hosp, Emergency Dept, Perugia, Italy

Mencacci, A:
 Santa Maria Misericordia Hosp, Microbiol Unit, Perugia, Italy

Tartaglia, D:
 Cisanello Hosp, Emergency Surg Dept, Pisa, Italy

Rossi, L:
 Cisanello Hosp, Emergency Surg Dept, Pisa, Italy

Ojetti, V:
 Catholic Univ, IRCCS, Fdn Policlin Gemelli, Rome, Italy

Petruzziello, C:
 Catholic Univ, IRCCS, Fdn Policlin Gemelli, Rome, Italy

Fiori, B:
 Catholic Univ, IRCCS, Fdn Policlin Gemelli, Rome, Italy

Bonenfant, J:
 CHU Rennes, Rennes, France

Piau-Couape, C:
 CHU Rennes, Rennes, France

Dejoies, L:
 CHU Rennes, Rennes, France

Garcia-Garcia, A:
 Complejo Asistencial Univ Salamanca, Emergency Dept, Salamanca, Spain

Cores-Calvo, O:
 Complejo Asistencial Univ Salamanca, Microbiol & Parasitol Lab, Salamanca, Spain

Van den Brand, C:
 Haaglanden Med Ctr, Emergency Dept, The Hague, Netherlands

Van Veen, S:
 Haaglanden Med Ctr, Microbiol Dept, The Hague, Netherlands

Laribi, S:
 CHU Tours, Tours, France

Lartigue, M:
 CHU Tours, Tours, France
ISSN: 03057453





JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Editorial
OXFORD UNIV PRESS, GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 74 Número: 10
Páginas: 3069-3076
WOS Id: 000491253800035
ID de PubMed: 31257423
imagen Open Access

MÉTRICAS